Meningococcal infections. 2. Field trial of group C meningococcal polysaccharide vaccine in 1969-70.
- 1 January 1971
- journal article
- Vol. 45 (3), 279-82
Abstract
A second large-scale field trial of group C meningococcal polysaccharide vaccine in US Army recruits confirmed the efficacy and safety of the vaccine. When the results of all studies over a 2-year period were combined, the reduction in group-specific disease rates was 89.5%.This publication has 10 references indexed in Scilit:
- Meningococcal infections. 1. Prevalence of serogroups causing disease in US Army personnel in 1964-70.1971
- EVALUATION OF GROUP C MENINGOCOCCAL POLYSACCHARIDE VACCINE IN MARINE RECRUITS, SAN DIEGO, CALIFORNIA1American Journal of Epidemiology, 1970
- Cutaneous Reactions and Antibody Response to Meningococcal Group C Polysaccharide Vaccines in ManThe Journal of Infectious Diseases, 1970
- Prevention of Meningococcal Disease by Group C Polysaccharide VaccineNew England Journal of Medicine, 1970
- HUMAN IMMUNITY TO THE MENINGOCOCCUSThe Journal of Experimental Medicine, 1969
- HUMAN IMMUNITY TO THE MENINGOCOCCUSThe Journal of Experimental Medicine, 1969
- HUMAN IMMUNITY TO THE MENINGOCOCCUSThe Journal of Experimental Medicine, 1969
- PREVALENCE OF MENINGOCOCCAL SEROGROUPS AND DESCRIPTION OF THREE NEW GROUPS1American Journal of Epidemiology, 1968
- Respiratory Disease and the AdenovirusesMedical Clinics of North America, 1967
- Serological typing of meningococci by means of micro-precipitationAntonie van Leeuwenhoek, 1961